Multiplex iterative plasmid engineering for combinatorial optimization of metabolic pathways and diversification of

Yifan Li1, Qun Gu, Zhenquan Lin

  • 1Key Laboratory of Systems Bioengineering, Ministry of Education, and Department of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University , Tianjin 300072, People's Republic of China.

ACS Synthetic Biology
|September 18, 2013
PubMed
Summary

Multiplex Iterative Plasmid Engineering (MIPE) enables rapid, customized diversification of plasmid sequences. This method efficiently generates large libraries for optimizing biological systems in synthetic biology and metabolic engineering.

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...